NEW YORK, March 8, 2018 /PRNewswire/ --
According to Hexa Research, the U.S. medical cannabis market was esteemed to be valued at USD 5.44
billion in 2016 and is anticipated to be valued at USD 19.48 billion by 2024. The projected
growth is a direct effect of the growing acceptance of cannabis products around the country. A wider range of consumers are aware
of the medical advantages associated with cannabis, particularly for patients dealing with cancer, chronic pain and diabetes.
Chronic pain accounted for 46 percent of the U.S. cannabis medical market share in 2016. According to the research, the solid
cannabis edibles segment in 2016, within the U.S. market generated $2.47 billion in revenue and is
expected to continue to dominate the cannabis industry to 2024. WeedMD Inc (OTC: WDDMF), Kush Bottles, Inc. (OTC: KSHB), Cannabis
Sativa, Inc. (OTC: CBDS), Phivida Holdings Inc. (OTC: PHVAF), AXIM Biotechnologies, Inc. (OTC: AXIM)
California's new recreational cannabis laws went into effect on January 1st, 2018.
A report by Fortune indicates that, "In order to collect $1 billion a year in taxes, the state will need to reach a
projected $7 billion in annual legal recreational cannabis sales. At that rate, California would easily be
the country's largest legal marijuana market, as the entire legal cannabis industry in the U.S. is expected to pull in
roughly $10 billion in total sales for 2017. That number would almost certainly get a boost in the coming years, as
legal markets grow in California and other states, such as Nevada and Massachusetts."
WeedMD Inc (OTC: WDDMF) is also listed on the TSX Venture Exchange under the ticker symbol 'WMD'. Just announced
breaking news this morning that, "to announce the signing of a letter of intent ("LOI") to form a joint venture focused on
cannabis-infused beverages. The new joint venture company, Cannabis Beverages Inc. ("CanBev"), plans to develop a production
facility at WeedMD's state-of-the-art greenhouse in Strathroy, Ontario. CanBev will operate one
of the first cannabis-infused beverage production facilities in Canada. The joint venture
partnership will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the medical and future
adult-use cannabis markets.
WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages and will designate
production space at its 610,000 sq. ft. state-of-the-art facility in Strathroy for CanBev's
operation. As an emerging cGMP certified food grade production plant, WeedMD's Strathroy
facility will equip CanBev with extensive production infrastructure, including 25,000 sq. ft. of packaging area and cold storage,
as well as adequate space to expand for future growth.
"As WeedMD builds out its production footprint, we will focus on product innovation, extending our product line and building
new brands. Canadian medical consumers, especially those in seniors' care, are interested in functional beverages as they
integrate cannabis into their medical treatment plans," said Michael Kraft, Chairman of WeedMD.
"We are eager to work alongside Phivida's world-class management team to develop cannabinoid-infused beverages and brands for
both the medical and adult-use markets."
Phivida will be responsible for product innovation, research and development, formulation and branding. Phivida will also
sublicense encapsulation technologies to CanBev for enhanced bioavailability and solubility and create new consumer brands to
serve target consumer segments in the pending adult-use market.
"Phivida is pleased to partner with an industry leader and build towards a leadership share of the global cannabis-infused
beverage market," said John-David A. Belfontaine, President and Chairman of Phivida. "WeedMD is
the ideal partner for Phivida, as they will provide CanBev with the ability to distribute into the federally legal medicinal
cannabis market in Canada and apply for a license for cultivation and sales under the ACMPR.
WeedMD provides CanBev with solid infrastructure, strong management, world class genetics and proven success in the Canadian
health care market. Phivida provides CanBev with the opportunity to bring our premium cannabinoid-infused beverages to patients
and consumers across Canada and bring federally legal cannabis-infused consumer packaged goods
and brands to the Canadian market for the first time in the history of the industry."
Kush Bottles, Inc. (OTCQB: KSHB) is a dynamic sales platform that provides unique products and services for both
businesses and consumers in the cannabis industry. On March 6, 2018, the company announced it has
been selected by FunkSac, LLC to be the exclusive distributor for its line of flagship FunkGuard products. FunkSac® which was
named by Entrepreneur Magazine as one of "10 Cannabis Startups You Need to Watch," was funded in part by Snoop Dogg's Casa Verde
Capital. The company is veteran-owned, based in Denver, CO and provides compliant packaging
solutions used in both medical and recreational markets. Under the terms of the agreement, Kush Bottles will distribute the line
of FunkGuard products to FunkSac's existing customer base, as well as across Kush Bottles' national platform. FunkSac® will
continue to implement its own sales and marketing initiatives in conjunction with the additional support from Kush Bottles.
Cannabis Sativa, Inc. (OTCQB: CBDS) is engaged in the licensing of cannabis related intellectual property, marketing
and branding for cannabis-based products and services, operation of cannabis related technology services, and ancillary business
activities. On January 16, 2018, the company announced that its subsidiary, PrestoDoctor, is
expanding its online medical marijuana recommendation services into New York. PrestoDoctor
currently serves patients via both their online platform and with dispensary kiosks operating in California and Nevada and will now extend their online services to patients
located in the State of New York. To use PrestoDoctor's online services, interested patients
must sign up for an account and complete a profile. They are then eligible to choose an appointment time and video chat with one
of PrestoDoctor's licensed physicians. Patients can immediately receive a digital recommendation and an official copy will arrive
in the mail a few days later.
Phivida Holdings Inc. (OTC: PHVAF) is a premier brand of cannabidiol (CBD) products. Phivida's Nano-CBD™ is infused
into functional beverages, foods and supplements containing a proprietary blend of phytonutraceuticals studied to target a range
of health conditions, from chronic pain to terminal diseases. Just earlier today with WeedMD Inc. the company announced an LOI to
form a joint venture focused on cannabis-infused beverages. "Phivida is pleased to partner with an industry leader and build
towards a leadership share of the global cannabis-infused beverage market," said John-David A.
Belfontaine, President and Chairman of Phivida. "WeedMD is the ideal partner for Phivida, as they will provide CanBev with
the ability to distribute into the federally legal medicinal cannabis market in Canada and apply
for a license for cultivation and sales under the ACMPR. WeedMD provides CanBev with solid infrastructure, strong management,
world class genetics and proven success in the Canadian health care market. Phivida provides CanBev with the opportunity to bring
our premium cannabinoid-infused beverages to patients and consumers across Canada and bring
federally legal cannabis-infused consumer packaged goods and brands to the Canadian market for the first time in the history of
the industry."
AXIM Biotechnologies, Inc. (OTCQB: AXIM) focuses on the research, development and production of cannabinoid-based
pharmaceutical, nutraceutical and cosmetic products. On February 6, 2018, the company announced
that it has entered into a binding distribution agreement for its proprietary cannabinoid-based nutraceutical chewing gum product
CanChew+® to be distributed throughout the country of Thailand. The non-exclusive agreement,
which was reached on January 24, 2018, and will remain in effect for one year, retains AXIM as the
sole owner and manufacturer of the product while assigning trademark and likeness rights to the distributor specifically for the
country of Thailand. The agreement sets clear financial obligations for the distributor
including a minimum purchase and upfront production costs. Thailand, with an estimated
population of more than 68 million, has been pushing toward access to cannabinoid-based products. As the Company continues its
clinical development program on cannabinoid-based pharmaceutical treatments, it will make acceptance of the benefits of these
nutraceutical products more possible.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For WeedMD inc financial news dissemination and PR services, FinancialBuzz.com has
been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or
negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are
commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of
the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR
advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post
information about any companies the information contained herein is not intended to be used as the basis for investment decisions
and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or
solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or
losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or
presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their
investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and
financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by
the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives,
other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and
legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless
of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please
visit: http://www.financialbuzz.com
For further information:
Media Contact: info@financialbuzz.com , +1-877-601-1879
SOURCE FinancialBuzz.com